On Tuesday, United Therapeutics Corp (NASDAQ: UTHR) opened lower -14.32% from the last session, before settling in for the closing price of $328.40. Price fluctuations for UTHR have ranged from $266.98 to $417.82 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 14.71% over the last five years. Company’s average yearly earnings per share was noted 13.30% at the time writing. With a float of $43.99 million, this company’s outstanding shares have now reached $45.07 million.
The firm has a total of 1305 workers. Let’s measure their productivity. In terms of profitability, gross margin is 89.0%, operating margin of 46.88%, and the pretax margin is 52.23%.
United Therapeutics Corp (UTHR) Insider Activity
A key investor’s attitude towards the stock of the Drug Manufacturers – Specialty & Generic industry is another important factor to consider. The insider ownership of United Therapeutics Corp is 2.49%, while institutional ownership is 99.59%. The most recent insider transaction that took place on Jun 09 ’25, was worth 3,904,496. In this transaction CFO AND TREASURER of this company sold 12,000 shares at a rate of $325.37, taking the stock ownership to the 8,118 shares. Before that another transaction happened on Jun 02 ’25, when Company’s CFO AND TREASURER sold 12,000 for $325.82, making the entire transaction worth $3,909,893. This insider now owns 8,118 shares in total.
United Therapeutics Corp (UTHR) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 13.30% per share during the next fiscal year.
United Therapeutics Corp (NASDAQ: UTHR) Trading Performance Indicators
Check out the current performance indicators for United Therapeutics Corp (UTHR). In the past quarter, the stock posted a quick ratio of 5.23. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.24. Likewise, its price to free cash flow for the trailing twelve months is 11.27.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 25.06, a number that is poised to hit 7.31 in the next quarter and is forecasted to reach 29.41 in one year’s time.
Technical Analysis of United Therapeutics Corp (UTHR)
Analysing the last 5-days average volume posted by the [United Therapeutics Corp, UTHR], we can find that recorded value of 0.89 million was better than the volume posted last year of 0.48 million. As of the previous 9 days, the stock’s Stochastic %D was 50.04%. Additionally, its Average True Range was 11.81.
During the past 100 days, United Therapeutics Corp’s (UTHR) raw stochastic average was set at 12.34%, which indicates a significant increase from 12.05% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 67.06% in the past 14 days, which was higher than the 43.20% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $302.31, while its 200-day Moving Average is $341.86.
